Thomas W. Dubensky, President at Tempest Therapeutics, Inc. (TPST), bought 2,000 shares at $4.78 ($10K) on 2022-01-07, disclosed to the SEC on 2022-01-11.
Open-market purchase of $10k TPST by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |
| ADRO | SELL | 2017-03-10 | $274K | — | Filing → |